drugset / Trial / NCT01757275
High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To describe the rate of clinically significant rebleeding during 72 hours continuous i.v. infusion of high dose esomeprazole Na in patients in China with primary successful endoscopic haemostatic therapy of a bleeding peptic ulcer, with cimetidine i.v. in
Timeline
- Start
- 2013-02
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cimetidine | Small molecule | 60 mg | Intravenous |
| Subject | Esomeprazole | Small molecule | 8 mg | Intravenous |
| Subject | Esomeprazole | Small molecule | 40 mg | Intravenous |